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The role of abnormal DNA methyltransferase activity in the de-
velopment and progression of cancer is an essential and rapidly
growing area of research, both for improved diagnosis and treat-
ment. However, current technologies for the assessment of methyl-
transferase activity, particularly from crude tumor samples, limit this
work because they rely on radioactivity or fluorescence and require
bulky instrumentation. Here, we report an electrochemical platform
that overcomes these limitations for the label-free detection of
human DNA(cytosine-5)-methyltransferase1 (DNMT1) methyltransfer-
ase activity, enabling measurements from crude cultured colorectal
cancer cell lysates (HCT116) and biopsied tumor tissues. Our
multiplexed detection system involving patterning and detection
from a secondary electrode array combines low-density DNA
monolayer patterning and electrocatalytically amplified DNA
charge transport chemistry to measure selectively and sensitively
DNMT1 activity within these complex and congested cellular
samples. Based on differences in DNMT1 activity measured with
this assay, we distinguish colorectal tumor tissue from healthy
adjacent tissue, illustrating the effectiveness of this two-electrode
platform for clinical applications.
DNA electrochemistry | methylation detection | electrocatalysis
DNA methylation powerfully influences gene expression incells (1, 2). DNA methyltransferases are responsible for
maintaining a genomic pattern of methyl groups, covalently
added to cytosine at predominantly 5ʹ-CG-3ʹ sites. Although es-
sential for many cellular processes, aberrant methylation is associ-
ated with cancer. In particular, abnormal activity of DNA
methyltransferases can lead to hypermethylation, which can silence
tumor suppressor genes and promote cancerous transformations
(3–6). The most abundant mammalian methyltransferase and an
important diagnostic target is DNA(cytosine-5)-methyltransferase1
(DNMT1), which preferentially methylates hemimethylated
DNA using the cofactor S-adenosyl-L-methionine (SAM) (7–10).
Current measurements of DNMT1 activity require [methyl-3H]-
SAM to observe radioactive labeling of DNA (8, 11), or expensive
fluorescence or colorimetric reagents with antibodies that require
large instrumentation (12–15), both of which are significant obsta-
cles that impede more widespread assessment of DNMT1 activity.
Traditionally, electrochemistry has been used to overcome such
limitations for biomolecule detection, as electrochemical methods
are low cost, portable, and require only modest instrumentation
(16, 17). However, electrochemical detection schemes have typi-
cally been restricted to measurements of highly purified samples
because of the increased congestion and decreased accessibility of
surface (vs. solution) platforms. Electrochemistry has been used to
detect nucleic acids with high sensitivity and without the need for
PCR amplification in bacterial lysate and serum (18–22), but
protein detection remains a challenge (23–26). In fact, although
protein detection from simple serum has been accomplished (27,
28), to date no reported electrochemical systems have effectively
detected active protein, of any kind, from crude cell lysate.
We have recently developed a unique electrochemical de-
tection architecture aimed at overcoming the challenges asso-
ciated with protein detection from complex biological samples.
This multiplexed detection system involves a substrate plate
consisting of a 15-electrode array and a complementary patterning
and detection plate also containing a 15-electrode array, which
combines low-density DNA monolayer patterning with the elec-
trocatalytically amplified measurement of DNA charge transport
(DNACT) chemistry at a secondary electrode (29). The low-density
DNA monolayer enables protein access to the DNA even in highly
congested lysate samples, whereas electrocatalytic signal amplifica-
tion markedly increases sensitivity. We use measurements of DNA
CT through the DNA helices in the monolayer because of the high
sensitivity of this chemistry to perturbations in base stacking caused
by mismatches, lesions, and protein binding (30, 31). Methylene
blue, a freely diffusing redox-active probe that is activated by DNA
CT, interacts with the DNA stack and thereby reports on the in-
tegrity of DNA CT through the monolayer. We use direct detection
from the patterning/detection electrode of the turnover of the
electrocatalytic partner to methylene blue, ferricyanide, as a mea-
surement of the amount of DNA present on the substrate electrode.
We generally have found amplification to be >10-fold (29, 30).
Here, for the first time to our knowledge, we demonstrate the
effectiveness of this platform for the detection of human DNMT1
activity from crude lysates of colorectal tumor biopsies, using
a methylation-sensitive restriction enzyme to convert the methyl-
ation state of the DNA into an electrochemical signal. This strategy
enables the detection of a methyl group, even though methylation
itself does not significantly affect DNA CT (Fig. 1) (32, 33).
Electrodes patterned with DNA containing the preferred DNMT1
methylation site (a hemimethylated 5ʹ-CG-3ʹ site) are first treated
with the lysate sample. Electrodes are then treated with a re-
striction enzyme that is sensitive to methylation at this site. If the
DNA is fully methylated by active DNMT1 in the lysate sample,
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the restriction enzyme does not cut the DNA, and there is an
electrochemical signal owing to amplified DNA CT. If, in contrast,
the DNA is not methylated by active DNMT1 in the lysate sample,
the DNA remains hemimethylated (or unmethylated if this non-
preferred substrate is used); the restriction enzyme can then cleave
the DNA, significantly decreasing the amount of DNA on the
surface, and thus diminishing the electrochemical signal from DNA
CT. As our electrochemical platform uses electrocatalytic signal
amplification involving a freely diffusing electrocatalyst (methylene
blue), in contrast with earlier work (33), the need for redox-labeled
DNA is eliminated.
Using this electrochemical platform and assay, we demon-
strate the efficient detection of DNMT1 activity in crude lysates
from both cultured human colorectal cancer cells (HCT116) and
colorectal tissue samples. Femtomoles of DNMT1 in cellular
samples are rapidly detected without the use of antibodies,
fluorescence, or radioactive labels. Moreover, we distinguish
colorectal tumor tissue from healthy adjacent tissue through
differences in DNMT1 activity, illustrating the effectiveness of
this two-electrode platform for clinical applications.
Results and Discussion
Electrochemical Platform. Using a 15-pin setup, low-density DNA
monolayers were formed on one set of electrode surfaces by
DNA patterning from a secondary electrode. DNA substrates
were optimized for length to balance the on–off signal differential
with the ability of proteins to access the binding site; oligonu-
cleotide lengths were tested with 10 nucleotides shorter and
longer than the 26-mer used. For monolayer formation, thiol
monolayers with 50% azide and 50% phosphate head groups first
were prepared on the gold pins. We have previously characterized
such low-density monolayers, and have found the total DNA
coverage to be 20 pmol/cm2 (34). Subsequently, specific DNA
sequences were tethered to individual pins using electrochemically
activated Cu1+ click chemistry (29). The secondary electrode
activates the inert copper catalyst precursor only at specific loca-
tions on the primary electrode surface. Multiple sequences of
DNA with different methylation states in the restriction enzyme
binding site were thereby patterned onto particular electrodes
(Fig. 1). The multiplexed array allows five experimental conditions
to be run in triplicate, enabling simultaneous detection from
healthy tissue and tumor tissue along with a positive control.
Electrochemical measurements were obtained by constant po-
tential amperometry over 90 s. Electrodes were measured after
treatment with methyltransferase, either in its purified form or as
a component of crude lysate, and again after treatment with 1,500
units/mL of the restriction enzyme BssHII. Lysate was prepared
from cultured cells through a simple treatment of cell disruption
followed by buffer exchange. Purified DNMT1 was first used to
establish the sensitivity and selectivity of this platform (Fig. S1)
and was subsequently included alongside lysate activity measure-
ments as a positive control. The DNA-mediated signal remains
Fig. 1. Electrochemical platform (Right) and scheme (Left) for the detection of human methyltransferase activity from crude cell lysates. (Right) The elec-
trochemical detection platform contains two electrode arrays, each with 15 electrodes (1-mm diameter each) in a 5 × 3 array. Multiple DNAs are patterned
covalently to the substrate electrode by an electrochemically activated click reaction initiated with the patterning electrode array. Once a DNA array is
established on the substrate electrode platform, electrocatalytic detection is then performed from the top patterning/detection electrode. (Left) Overview of
electrochemical detection scheme at each electrode of the 5 × 3 array. DNA, patterned onto the bottom electrode using the copper-activated click chemistry,
is electrocatalytically detected from the top electrode using methylene blue (MB+) as the electrocatalyst and ferricyanide for amplification. Crude cell lysate is
then added to the surface containing the patterned DNA. If methyltransferase (green) is present (blue arrows), the hemimethylated DNA on the electrode is
methylated (green dot) by the methyltransferase to a fully methylated duplex; if methyltransferase is not present (red arrows), the hemimethylated DNA
is not further methylated. A methylation-specific restriction enzyme, BssHII (purple), is then added. If the DNA is fully methylated (blue arrows), the elec-
trochemical signal remains protected and the DNA is not cleaved. However, if the DNA remains hemimethylated (red arrows), it is cut by the restriction
enzyme, and the electrocatalytic signal associated with MB+ binding to DNA is diminished significantly.
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protected from restriction, giving the same signal before and after
enzyme treatment, or fully “on,” when the electrode is first treated
with 65 nM DNMT1 protein on a hemimethylated DNA sub-
strate in the presence of the SAM cofactor, although protein
DNMT1 is easily detectable at a 15-nM concentration with 48 ±
3% signal protection after restriction. For 65 nM DNMT1
without SAM, only 33 ± 5% signal protection is observed. Sim-
ilarly, little DNA protection (31 ± 6% signal protection) is ob-
served with the unmethylated substrate. This is explained by the
strong preference of DNMT1, as a maintenance methyltransferase,
for a hemimethylated substrate.
Fig. 2 shows the raw data collected for two individual elec-
trodes treated with crude lysate, one in which the signal is on in
the presence of the SAM cofactor and one in which the signal is
turned “off” in the absence of cofactor, given DNA restriction in
the absence of methylation. Additionally, the reproducibility of
the platform is shown (Fig. 2), with the 15 individual electrodes
of a single assay. Interestingly, high concentrations of lysate
were found to diminish the electrochemical signal, likely due to
crowding on the DNA-modified electrode, limiting access and
binding of the methyltransferase. Multiple concentrations of
lysate were tested (Fig. S2); a concentration corresponding to
4,000 cells per electrode was dilute enough to allow access of
DNMT1 to the DNA on the surface while still containing suf-
ficient DNMT1 to produce measurable activity.
To further combat signal decreases caused by undesired DNA-
binding proteins, after electrodes are treated with lysate, a pro-
tease treatment step is incorporated to remove remaining bound
protein before the electrochemical measurements. This protease
step further minimizes the possibility of remaining protein being
bound either to the DNA or directly to the surface that could
interfere with electrochemical measurements. Methyltransferase
activity is then determined by the percent signal remaining after
BssHII treatment. If the DNA is cut by the restriction enzyme,
the signal is low, indicating little methyltransferase activity. It is
noteworthy that the percent signal remaining is always nonzero
because, even after restriction, a DNA fragment remains that
can generate an electrochemical response with the noncovalent
methylene blue redox probe; electrochemical amplification is pro-
portional to the amount of bound methylene blue, and therefore
to DNA length.
Differential Detection of DNMT1 Activity from Multiple Crude
Cultured Cell Lysates. We then tested the ability of the platform
to differentiate between lysate from a parent (HCT116 wild-type)
colorectal carcinoma cell line and a cell line that does not express
DNMT1 (HCT116 DNMT1−/−). As shown in Fig. 3, specific de-
tection of DNMT1 activity is dependent on both the methylation
state of the substrate and the presence of the cofactor SAM. The
“signal-on” specificity for the hemimethylated DNA substrate in-
dicates unambiguous DNMT1 activity (maintenance methylation),
and not activity by other human methyltransferases, DNMT3a or
DNMT3b, which do not show this substrate preference (de novo
methylation) (7). Signal is dependent on the presence of DNMT1
(purified or from parent lysate) as well as the cofactor SAM (Fig.
3B) and the hemimethylated substrate (Fig. 3A). The remaining
electrodes, treated either with parent lysate without SAM, or
DNMT1−/− lysate independent of the cofactor, had significantly
attenuated signals after restriction enzyme treatment.
Detection of DNMT1 Activity from Human Tumor Tissue. Human bi-
opsy tissue samples were similarly evaluated, and tumor tissue was
readily distinguished from adjacent normal tissue (Fig. 3). Tissue
biopsy samples were purchased from a commercial source and
were thus handled and stored using conventional methods (snap
freezing in liquid nitrogen after removal and storage at −80 °C for
upward of 1 mo). The optimal amount of tissue for detection from
these samples was found to be ∼500 μg per electrode; typical colon
punch biopsies yield 350 mg of tissue (35). Samples of colorectal
carcinoma tissue as well as the adjacent healthy tissue were pre-
pared just as the cultured cell lysate, and showed differential ac-
tivity with our electrochemical platform. The tumor sample, which
showed greater signal protection, was sensitive both to substrate
and to cofactor, consistent with high DNMT1 methyltransferase
activity, similar to the cultured parent colorectal carcinoma cells.
In contrast, the normal tissue sample showed low methyl-
transferase activity, as seen through the reduced electrochemical
signal (Fig. 3). These data clearly indicate that tumors can be
effectively differentiated from healthy tissue through electro-
chemical DNMT1 measurement with our platform. By Western
blot, the relative abundance of DNMT1 in the tumor tissue
compared with healthy tissue was quantitatively consistent with
the electrochemical results (Fig. S3).
Lysate activities were also tested by a 3H-SAM assay, and rel-
ative activities of the various samples were comparable to those
determined electrochemically (Fig. S4). However, as is typical for
such radioactivity assays, activity measurements observed among
trials of the 3H-SAM assay were extremely variable, much more
so than with the electrochemical platform. Activity differences
Fig. 2. Detection and reproducibility of DNMT1 activity in cell lysates using
electrochemical platform. (Upper) Raw data from single electrodes in the
presence or absence of SAM cofactor. In blue is the preliminary scan after an
electrode modified with hemimethylated DNA has been treated with parent
lysate, followed by treatment with 1 μM protease in phosphate buffer, both
at 37 °C. In red is the scan after the electrode was treated with 1,500 units/mL
BssHII for 1.5 h at 37 °C. (Upper Left) Final scan from an electrode with 160 μM
SAM added to the lysate; the signals essentially overlay, indicating an “on”
signal. (Upper Right) Final scan from an electrode without SAM added to the
lysate; this produces an “off” signal. The constant potential amperometry was
run for 90 s with an applied potential of 320 mV to the secondary electrode
and −400 mV to the primary electrode. All scans were performed in Tris buffer
(10 mM Tris, 100 mM KCl, 2.5 mM MgCl2, 1 mM CaCl2, pH 7.6) with 4 μM MB
and 300 μM potassium ferricyanide. (Lower) Reproducibility within the two-
electrode multiplexed array. Orientation of the tested conditions on the 5 × 3
array is shown (Inset) with circular electrodes colored to correspond with ac-
tivity data represented in the bar graph. Both the electrodes treated with
65 nM purified DNMT1 on hemimethylated DNA with 160 μM SAM (green) and
those treated with parent (WT) lysate in the presence of SAM (solid blue) show
full signal protection. On electrodes without added SAM (blue striped and red
striped) and on DNMT1 −/− lysate-treated electrodes in the presence of SAM
(solid red), no signal protection is observed. Bar graph data are raw without
standardization and error bars represent the SD over three measurements.
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between the tumor and healthy tissue were seen only at con-
centrations of ∼1 mg of tissue per sample, significantly higher
than what is needed for electrochemical detection. The time re-
quired to obtain the data for the 3H-SAM assay was additionally
substantially longer.
Implications. DNMT1 is an important clinical diagnostic target
due to its connection to aberrant genomic methylation, which is
linked to tumorigenesis. Direct detection of methyltransferase
activity from crude tissue lysates provides an early method of
cancer screening and can also inform treatment decisions.
However, current approaches for detection of methyltransferase
activity rely on radioactive or fluorescent labels, antibodies, and
obtrusive instrumentation that limit their application in labora-
tories and clinics. Although electrochemical approaches gener-
ally overcome these limitations, direct detection of proteins from
crude samples remains challenging because of the complexity of
crude biological lysates, as well as the sensitivity required to
analyze the limited material of small clinical biopsy samples.
Our electrochemical assay for DNMT1 methylation effectively
circumvents these problems. Methylation is detected through the
presence or absence of DNA surface restriction followed by elec-
trocatalytic amplification. We avoid clogging the platform through
the formation of low-density DNA monolayers, enabling target
DNA-binding proteins in the lysate ample access to the individual
DNA helices on the surface. Our platform is also sensitive and
selective without the use of radioactivity, fluorescence, or anti-
bodies through the combination of electrocatalytic signal amplifi-
cation and the sensitivity of DNA CT chemistry to report changes
to the integrity of the DNA. This allows for detection of DNMT1
from both cultured colorectal carcinoma cells and tissue biopsy
specimens. No difficult or time-consuming purification steps are
necessary, and, for each electrode, only ∼4,000 cultured cells or
∼500-μg tissue sample are required. Importantly, because of the
multiplexed nature of this platform, we are able to assay for sub-
strate specificity while simultaneously measuring normal tissue and
tumor tissue lysates. Therefore, with our platform, healthy tissue is
easily distinguished from tumor tissue using very small amounts of
sample. More generally, this work may be applicable to sensing
other DNA modifications and certainly should represent an im-
portant step in new electrochemical biosensing technologies.
Methods
DNA Monolayer Formation. The two-electrode arrays were constructed as
previously reported (29). The multiplexed setup consisted of two comple-
mentary arrays containing 15 × 1-mm-diameter gold rod electrodes em-
bedded in Teflon. Gold surfaces were polished with 0.05-μm polish before
monolayer assembly. Mixed monolayers were formed on one of the plates
using an ethanolic solution of 1 M 12-azidododecane-1-thiol (C12thiolazide)
and 1 M 11-mercaptoundecylphosphoric acid (Sigma Aldrich). Surfaces were
incubated in the thiol solution for 18–24 h, followed by rinsing with ethanol
and phosphate buffer (5 mM phosphate, pH 7.0). The water-soluble
[Cu(phendione)2]
2+ (phendione = 1,10-phenanthroline-5,6-dione) was synthe-
sized by mixing two equivalents of phendione with copper sulfate in water.
Covalent attachment of DNA to mixed monolayers containing 50% azide
head group and 50% phosphate head group through electrochemically ac-
tivated click chemistry was accomplished by applying a sufficiently negative
potential to the secondary electrode. Specifically, a constant potential of
−350 mV was applied to a secondary electrode for 25 min, allowing for
precise attachment of the appropriate DNA to a primary electrode. Forty μL
of 100 μM catalyst and 80 μL of 50 μM DNA in Tris buffer (10 mM Tris,
100 mMKCl, 2.5 mMMgCl2, 1 mMCaCl2, pH 7.6) were added to the platform for
covalent attachment.
Fig. 3. Dependence of lysate activity on the DNA substrate and cofactor. The positive control is 65 nM purified DNMT1 on hemimethylated DNA with 160 μM
SAM (green). All values are normalized to 100% protection of the purified DNMT1 electrodes. (Upper) Cultured cell lysate substrate (A) and cofactor (B)
dependence. Electrodes treated with parent (WT) lysate on the hemimethylated substrate in the presence of 160 μM SAM (blue) showed full signal protection,
whereas on an unmethylated substrate or in the absence of SAM (striped blue) no signal protection is observed. Independent of conditions, electrodes treated
with DNMT1 −/− lysate (red solid and striped) showed no signal protection. (Lower) Biopsy tissue substrate (C) and cofactor (D) dependence. Electrodes treated
with tumor lysate on the hemimethylated substrate in the presence of 160 μM SAM (blue) showed full signal protection, whereas on an unmethylated
substrate or in the absence of SAM (striped blue) no signal protection is observed. Independent of conditions, electrodes treated with normal tissue lysate (red
solid and striped) showed no signal protection. The data shown represent the aggregation of three independent replicate experiments, with three electrodes
per condition per experiment.
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Cell Culture and Lysate Preparation. HCT116 cells, either parent or DNMT1−/−
(Vogelstein Lab) (9), were grown in McCoy’s 5A media containing 10% FBS,
100 units/mL penicillin, and 100 μg/mL streptomycin, and were grown in
tissue culture flasks (Corning Costar) at 37 °C under a humidified atmosphere
containing 5% CO2.
Approximately 6 million cells were harvested from adherent cell culture
by trypsinization, followed by washing with cold PBS and pelleting by
centrifugation at 500g for 5 min. A nuclear protein extraction kit (Pierce
from Thermo Scientific) was used for cell lysis, with buffer then exchanged
by size exclusion spin column (10-kDa cutoff; Amicon) into DNMT1 activity
buffer (50 mM Tris·HCl, 1 mM EDTA, 5% glycerol, pH 7.8). Cell lysate was
immediately aliquoted and stored at −80 °C until use. A bicinchoninc assay
(Pierce) was used to quantify the total amount of protein in the lysate. The
total protein concentration at which the lysate was frozen was 35,000–
50,000 μg/mL.
Tissue samples were obtained from CureLine. Colorectal carcinoma as well
as healthy adjacent tissues were obtained. Approximately 150 mg of tissue
were homogenized manually, followed by nuclear extraction, buffer ex-
change, storage, and quantification as described above. The total protein
concentration at which the lysate was frozen was 35,000–50,000 μg/mL.
Electrochemistry. All electrochemistry was performed on a bipotentiostat
(BASinc.) with two working electrodes, a platinum wire auxiliary electrode and
a AgCl/Ag reference electrode. All electrochemistry was performed as constant
potential amperometry for 90 s with an applied potential of 320 mV to the
patterning/detecting electrode array and −400 mV to the substrate electrode
array relative to a AgCl/Ag reference electrode with a platinum auxiliary elec-
trode. All scans were performed in Tris buffer (10 mM Tris, 100 mMKCl, 2.5 mM
MgCl2, 1 mM CaCl2, pH 7.6) with 4 μM methylene blue and 300 μM potassium
ferricyanide. Scans were taken of each of the 15 secondary pin electrodes, and
the reported variation in the data represents the SE across 3 measurements of
3 electrodes, all at a given condition.
To incubate electrodes with desired proteins, a 1.5-mm-deep Teflon spacer
was clipped to the primary electrode surface. Each electrode is isolated in an
individual well that holds 4 μL of solution. For methyltransferase activity
detection, three electrodes on the device were always incubated with 65 nM
DNMT1 with 160 μM SAM and 100 μg/mL BSA as a positive control. For
electrodes incubated with lysate, lysate was either directly combined with
SAM to a final SAM concentration of 160 μM or the lysate was diluted in
DNMT1 activity buffer to the desired total protein concentration and then
combined with SAM to a final SAM concentration of 160 μM. For the tissue
lysate, 50 μg/mL BSA was also added. Each electrode had the desired solution
added to the well and incubated at 37 °C for 1.5 h in a humidified container.
The substrate electrode array was then treated with 1 μM protease solution
in phosphate buffer (5 mM phosphate, 50 mM NaCl, pH 7.0) for 1 h. The
surface was then thoroughly rinsed with phosphate buffer (5 mM phos-
phate, 50 mM NaCl, pH 7.0) and scanned. The electrodes were subsequently
incubated with the restriction enzyme BssHII at a concentration of 1,500
units/mL for 1.5 h at 37 °C in a humidified container. BssHII was exchanged
into DNMT1 activity buffer by size exclusion column (10 kDa, Amicon). The
electrodes were again rinsed with phosphate buffer and scanned.
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